The polymorphism not only affected the expression of the cathepsin Z gene, but experimental knockdown of cathepsin Z levels affected the expression of osteoporosis-associated genes11, suggesting an association between cathepsin Z expression, fragility fracture and the expression of osteoporosis-related genes in an estrogen-reduced, clinical situation. This evidence concerns the gene CTSZ and osteoporosis.